Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised



Rating:

Share or cite this content

Citations should be made in the following way:
B. Er (Ankara, Turkey), A. Er (Ankara, Turkey), D. Gulmez Kivanc (Ankara, Turkey), T. Sahin (Ankara, Turkey), B. Halacli (Ankara, Turkey), G. Durhan (Ankara, Turkey), E. Ortac Ersoy (Ankara, Turkey), G. Hazirolan (Ankara, Turkey), A. Alp (Ankara, Turkey), G. Metan (Ankara, Turkey), Z. Saribas (Ankara, Turkey), S. Arikan-Akdagli (Ankara, Turkey), S. Akinci (Ankara, Turkey), M. Ariyurek (Ankara, Turkey), A. Topeli (Ankara, Turkey), O. Uzun (Ankara, Turkey). Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19. 1884

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of ICU criteria for invasive pulmonary aspergillosis in critically ill patients Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a prospective study Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Lung resection for invasive pulmonary aspergillosis in neutropenic patients – risks and outcome Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Invasive pulmonary aspergillosis in immunosuppressed patients Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections Year: 2015 Model of diagnosis scoring, clinical and molecular profile of invasive pulmonary aspergillosis (IPA) in ICU patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD? Source: Eur Respir J, 50 (3) 1700532; 10.1183/13993003.00532-2017 Year: 2017 Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia Source: Annual Congress 2013 –COPD and infections Year: 2013 VATS-resection and lobectomy for invasive pulmonary aspergillosis in severely immunocompromised patients with hematologic diseases Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Predicting survival in hospitalized pulmonary hypertension patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary infections in neutropenic patients Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Non invasive spontaneous dual ventilation in critically ill patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Noninvasive ventilation in acute respiratory failure: the recipe for success Year: 2015 Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Pathological, bacteriological and non invasive cardiopulmonary evaluation of PRO-BAL in respiratory critically ill patients Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003 Fungal lung infections in critically-ill patients Source: International Congress 2016 – PG19 The lung in the septic critically-ill patient Year: 2016 Incidence and significance of venous thromboembolism in critically ill pulmonary tuberculosis patients Source: Eur Respir J, 56 (6) 2001753; 10.1183/13993003.01753-2020 Year: 2020 Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019